{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:41:04Z","timestamp":1777473664352,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Homoharringtonine (HHT) is a kind of cephalotaxus alkaloid used in traditional Chinese medicine. Although HHT has been successfully used as a therapeutic agent for leukemia, the drug resistance and toxicity are major concerns. MicroRNAs (miRNAs) have been identified to modulate cellular sensitivity to anticancer drugs. We examined the synergistic action between miR-370 and HHT <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic>.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The synergistic action between miR-370 and HHT was examined by flow cytometry. The effect of HHT on miR-370 expression was determined by quantitative RT-PCR (qRT-PCR). The expression of miR-370 and Forkhead box M1 (FoxM1) in 23 patients with newly diagnosed chronic-phase chronic myeloid leukemia (CML-CP) and 10 patients with blast-crisis CML (CML-BP) as well as miR-370\u2013targeted FoxM1 was determined by qRT-PCR and western blot analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Ectopic expression of miR-370 sensitized the CML K562 cell line to HHT by targeting FoxM1, the major regulator in cell proliferation and apoptosis. miR-370 significantly promoted HHT-mediated cell apoptosis and miR-370 and HHT cooperated in affecting FoxM1 expression. As well, miR-370 was moderately upregulated after HHT treatment in K562 cells. In addition, the expression of miR-370 was significantly reduced in CML patients as compared with healthy controls. Furthermore, the expression of miR-370 was lower in CML-BP than CML-CP patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>MiR-370 sensitized K562 cells to HHT by inducing apoptosis in part by downregulation of FoxM1 expression. These findings may provide further information for CML treatment with HHT.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1479-5876-11-265","type":"journal-article","created":{"date-parts":[[2013,10,23]],"date-time":"2013-10-23T07:50:10Z","timestamp":1382514610000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["MiR-370 sensitizes chronic myeloid leukemia K562 cells to homoharringtonine by targeting Forkhead box M1"],"prefix":"10.1186","volume":"11","author":[{"given":"MinRan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JiPing","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XiaoMing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HaiYu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LiXiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JiHui","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ChunYan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,10,23]]},"reference":[{"key":"2126_CR1","first-page":"163","volume":"58","author":"Chinese People\u2019s Liberation Army 18th Hospital","year":"1978","unstructured":"Chinese People\u2019s Liberation Army 18th Hospital: On the treatment of leukemias: clinical analysis of 72 cases. Zhonghua Yixue Zazhi. 1978, 58: 163-","journal-title":"Zhonghua Yixue Zazhi"},{"key":"2126_CR2","first-page":"319","volume":"3","author":"Hospital CPsLAt","year":"1977","unstructured":"Hospital CPsLAt: Harringtonine in acute leukemias. Clinical analysis of 31 cases. Chin Med J (Engl). 1977, 3: 319-324.","journal-title":"Chin Med J (Engl)"},{"key":"2126_CR3","first-page":"263","volume":"2","author":"Group CRC","year":"1976","unstructured":"Group CRC: Cephalotaxine esters in the treatment of acute leukemia. A preliminary clinical assessment. Chin Med J (Engl). 1976, 2: 263-272.","journal-title":"Chin Med J (Engl)"},{"key":"2126_CR4","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1128\/AAC.12.2.298","volume":"12","author":"DM Baaske","year":"1977","unstructured":"Baaske DM, Heinstein P: Cytotoxicity and cell cycle specificity of homoharringtonine. Antimicrob Agents Chemother. 1977, 12: 298-300. 10.1128\/AAC.12.2.298.","journal-title":"Antimicrob Agents Chemother"},{"key":"2126_CR5","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1182\/blood.V63.2.384.384","volume":"63","author":"AW Boyd","year":"1984","unstructured":"Boyd AW, Sullivan JR: Leukemic cell differentiation in vivo and in vitro: arrest of proliferation parallels the differentiation induced by the antileukemic drug harringtonine. Blood. 1984, 63: 384-392.","journal-title":"Blood"},{"issue":"1","key":"2126_CR6","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1182\/blood-2010-01-262808","volume":"117","author":"R Chen","year":"2011","unstructured":"Chen R, Guo L, Chen Y: Homoharringtonine reduced Mcl-1 expression and induced apoptosis in chronic lymphocytic leukemia. Blood. 2011, 117 (1): 156-164. 10.1182\/blood-2010-01-262808.","journal-title":"Blood"},{"key":"2126_CR7","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1182\/blood.V86.9.3322.bloodjournal8693322","volume":"86","author":"S O\u2019Brien","year":"1995","unstructured":"O\u2019Brien S, Kantarjian H, Keating M: Homoharringtonine therapy induces responses in patients with chronic myelogenous leukemia in late chronic phase. Blood. 1995, 86: 3322-3326.","journal-title":"Blood"},{"key":"2126_CR8","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1038\/sj.leu.2402775","volume":"16","author":"AJ Tipping","year":"2002","unstructured":"Tipping AJ, Mahon FX, Zafirides G, Lagarde V, Goldman JM, Melo JV: Drug responses of imatinib mesylate-resistant cells: synergism of imatinib with other chemotherapeutic drugs. Leukemia. 2002, 16: 2349-2357. 10.1038\/sj.leu.2402775.","journal-title":"Leukemia"},{"key":"2126_CR9","first-page":"967","volume":"46","author":"JA Neidhart","year":"1986","unstructured":"Neidhart JA, Young DC, Kraut E: Phase I trial of homoharringtonine administered by prolonged continuous infusion. Cancer Res. 1986, 46: 967-969.","journal-title":"Cancer Res"},{"key":"2126_CR10","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/sj.leu.2400608","volume":"11","author":"G Visani","year":"1997","unstructured":"Visani G, Russo D, Ottaviani E: Effects of homoharringtonine alone and in combination with alpha interferon and cytosine arabinoside on 'in vitro\u2019 growth and induction of apoptosis in chronic myeloid leukemia and normal hematopoietic progenitors. Leukemia. 1997, 11: 624-628. 10.1038\/sj.leu.2400608.","journal-title":"Leukemia"},{"issue":"2","key":"2126_CR11","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.gde.2006.02.012","volume":"16","author":"RW Carthew","year":"2006","unstructured":"Carthew RW: Gene regulation by microRNAs. Curr Opin Genet Dev. 2006, 16 (2): 203-208. 10.1016\/j.gde.2006.02.012.","journal-title":"Curr Opin Genet Dev"},{"key":"2126_CR12","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.molmed.2006.10.006","volume":"12","author":"R Garzon","year":"2006","unstructured":"Garzon R, Fabbri M, Cimmino A, Calin GA, Croce C: MicroRNA expression and function in cancer. Trends Mol Med. 2006, 12: 580-587. 10.1016\/j.molmed.2006.10.006.","journal-title":"Trends Mol Med"},{"key":"2126_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004, 116: 281-297. 10.1016\/S0092-8674(04)00045-5.","journal-title":"Cell"},{"key":"2126_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1158\/1535-7163.MCT-07-0573","volume":"7","author":"PE Blower","year":"2008","unstructured":"Blower PE, Chung JH, Verducci JS: MicroRNAs modulate the chemosensitivity of tumor cells. Mol Cancer Ther. 2008, 7: 1-9.","journal-title":"Mol Cancer Ther"},{"key":"2126_CR15","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ygyno.2009.01.014","volume":"113","author":"T Boren","year":"2009","unstructured":"Boren T, Xiong Y, Hakam A: MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy. Gynecol Oncol. 2009, 113: 249-255. 10.1016\/j.ygyno.2009.01.014.","journal-title":"Gynecol Oncol"},{"issue":"4","key":"2126_CR16","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1111\/j.1349-7006.2010.01489.x","volume":"101","author":"Y Li","year":"2010","unstructured":"Li Y, Zhu X, Gu J, Dong D, Yao J, Lin C, Huang K, Fei J: Anti-miR-21 oligonucleotide sensitizes leukemic K562 cells to arsenic trioxide by inducingapoptosis. Cancer Sci. 2010, 101 (4): 948-954. 10.1111\/j.1349-7006.2010.01489.x.","journal-title":"Cancer Sci"},{"issue":"8","key":"2126_CR17","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1158\/1541-7786.MCR-13-0007","volume":"11","author":"Y Feng","year":"2013","unstructured":"Feng Y, Wang L, Zeng J, Shen L, Liang X, Yu H, Liu S, Liu Z, Sun Y, Li W, Chen C, Jia J: FoxM1 is overexpressed in Helicobacter pylori-induced gastric carcinogenesis and is negatively regulated by miR-370. Mol Cancer Res. 2013, 11 (8): 834-844. 10.1158\/1541-7786.MCR-13-0007.","journal-title":"Mol Cancer Res"},{"key":"2126_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1476-4598-5-29","volume":"5","author":"E Bandr\u00e9s","year":"2006","unstructured":"Bandr\u00e9s E, Cubedo E, Agirre X, Malumbres R, Z\u00e1rate R, Ramirez N: Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer. 2006, 5: 29-39.","journal-title":"Mol Cancer"},{"key":"2126_CR19","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/sj.onc.1210648","volume":"27","author":"F Meng","year":"2008","unstructured":"Meng F, Wehbe-Janek H, Henson R, Smith H, Patel T: Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes. Oncogene. 2008, 27: 378-386. 10.1038\/sj.onc.1210648.","journal-title":"Oncogene"},{"issue":"1","key":"2126_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1476-4598-11-56","volume":"11","author":"X Zhang","year":"2012","unstructured":"Zhang X, Zeng J, Zhou M, Li B, Zhang Y, Huang T, Wang L, Jia J, Chen C: The tumor suppressive role of miRNA-370 by targeting FoxM1 in acute myeloid leukemia. Mol Cancer. 2012, 11 (1): 56-10.1186\/1476-4598-11-56.","journal-title":"Mol Cancer"},{"key":"2126_CR21","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/1477-7819-10-174","volume":"10","author":"H Lee","year":"2012","unstructured":"Lee H, Park CS, Deftereos G, Morihara J, Stern JE, Hawes SE, Swisher E, Kiviat NB, Feng Q: MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features. World J Surg Oncol. 2012, 10: 174-10.1186\/1477-7819-10-174.","journal-title":"World J Surg Oncol"},{"issue":"6","key":"2126_CR22","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/odi.12046","volume":"19","author":"KW Chang","year":"2013","unstructured":"Chang KW, Chu TH, Gong NR, Chiang WF, Yang CC, Liu CJ, Wu CH, Lin SC: miR-370 modulates insulin receptor substrate-1 expression and inhibits the tumor phenotypes of oral carcinoma. Oral Dis. 2013, 19 (6): 611-619. 10.1111\/odi.12046.","journal-title":"Oral Dis"},{"key":"2126_CR23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/1477-7827-1-66","volume":"1","author":"M Fraser","year":"2003","unstructured":"Fraser M, Leung B, Jahani-Asl A, Yan X, Thompson WE, Tsang BK: Chemoresistance in human ovarian cancer: the role of apoptotic regulators. Reprod Biol Endocrinol. 2003, 1: 66-10.1186\/1477-7827-1-66.","journal-title":"Reprod Biol Endocrinol"},{"issue":"7","key":"2126_CR24","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S1470-2045(13)70152-9","volume":"14","author":"J Jin","year":"2013","unstructured":"Jin J, Wang JX, Chen FF, Wu DP, Hu J, Zhou JF, Hu JD, Wang JM, Li JY, Huang XJ, Ma J, Ji CY, Xu XP, Yu K, Ren HY, Zhou YH, Tong Y, Lou YJ, Ni WM, Tong HY, Wang HF, Mi YC, Du X, Chen BA, Shen Y, Chen Z, Chen SJ: Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial. Lancet Oncol. 2013, 14 (7): 599-608. 10.1016\/S1470-2045(13)70152-9.","journal-title":"Lancet Oncol"},{"issue":"6","key":"2126_CR25","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.febslet.2013.01.012","volume":"587","author":"C Xu","year":"2013","unstructured":"Xu C, Dehong L, Ming YX, Ya Z, Liqun Y, Ting Z, Cui FM, Yun Z, Jian W: Stat3 inhibits WTX expression through up-regulation of microRNA-370 in Wilms tumor. FEBS Lett. 2013, 587 (6): 639-644. 10.1016\/j.febslet.2013.01.012.","journal-title":"FEBS Lett"},{"issue":"9","key":"2126_CR26","doi-asserted-by":"publisher","first-page":"e45825","DOI":"10.1371\/journal.pone.0045825","volume":"7","author":"Z Wu","year":"2012","unstructured":"Wu Z, Sun H, Zeng W, He J, Mao X: Upregulation of mircoRNA-370 induces proliferation in human prostate cancer cells by downregulating the transcription factor FOXO1. PLoS One. 2012, 7 (9): e45825-10.1371\/journal.pone.0045825.","journal-title":"PLoS One"},{"issue":"1","key":"2126_CR27","doi-asserted-by":"publisher","first-page":"e54556","DOI":"10.1371\/journal.pone.0054556","volume":"8","author":"L Christensen","year":"2013","unstructured":"Christensen L, Joo J, Lee S, Wai D, Triche TJ, May WA: FOXM1 is an oncogenic mediator in Ewing sarcoma. PLoS One. 2013, 8 (1): e54556-10.1371\/journal.pone.0054556.","journal-title":"PLoS One"},{"issue":"2","key":"2126_CR28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/cgt.2012.94","volume":"20","author":"C Yang","year":"2013","unstructured":"Yang C, Chen H, Yu L, Shan L, Xie L, Hu J, Chen T, Tan Y: Inhibition of FOXM1 transcription factor suppresses cell proliferation and tumor growth of breast cancer. Cancer Gene Ther. 2013, 20 (2): 117-124.","journal-title":"Cancer Gene Ther"},{"issue":"10","key":"2126_CR29","doi-asserted-by":"publisher","first-page":"e48160","DOI":"10.1371\/journal.pone.0048160","volume":"7","author":"AL Mencalha","year":"2012","unstructured":"Mencalha AL, Binato R, Ferreira GM, Du Rocher B, Abdelhay E: Forkhead box M1 (FoxM1) gene is a new STAT3 transcriptional factor target and is essential for proliferation, survival and DNA repair of K562 cell line. PLoS One. 2012, 7 (10): e48160-10.1371\/journal.pone.0048160.","journal-title":"PLoS One"},{"issue":"11","key":"2126_CR30","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1093\/carcin\/bgs249","volume":"33","author":"L Xia","year":"2012","unstructured":"Xia L, Mo P, Huang W, Zhang L, Wang Y, Zhu H, Tian D, Liu J, Chen Z, Zhang Y, Chen Z, Hu H, Fan D, Nie Y, Wu K: The TNF-\u03b1\/ROS\/HIF-1-induced upregulation of FoxMI expression promotes HCC proliferation and resistance to apoptosis. Carcinogenesis. 2012, 33 (11): 2250-2259. 10.1093\/carcin\/bgs249.","journal-title":"Carcinogenesis"},{"issue":"1","key":"2126_CR31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s12032-010-9777-8","volume":"29","author":"JS Wang","year":"2012","unstructured":"Wang JS, Ren TN, Xi T: Ursolic acid induces apoptosis by suppressing the expression of FoxM1 in MCF-7 human breast cancer cells. Med Oncol. 2012, 29 (1): 10-15. 10.1007\/s12032-010-9777-8.","journal-title":"Med Oncol"},{"issue":"11","key":"2126_CR32","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1093\/carcin\/bgq185","volume":"31","author":"S Nakamura","year":"2010","unstructured":"Nakamura S, Hirano I, Okinaka K, Takemura T, Yokota D, Ono T, Shigeno K, Shibata K, Fujisawa S, Ohnishi K: The FOXM1 transcriptional factor promotes the proliferation of leukemia cells through modulation of cell cycle progression in acute myeloid leukemia. Carcinogenesis. 2010, 31 (11): 2012-2021. 10.1093\/carcin\/bgq185.","journal-title":"Carcinogenesis"},{"issue":"1","key":"2126_CR33","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/jcb.22770","volume":"112","author":"Z Wang","year":"2011","unstructured":"Wang Z, Li Y, Ahmad A, Banerjee S, Azmi AS, Kong D, Wojewoda C, Miele L, Sarkar FH: Down-regulation of Notch-1 is associated with Akt and FoxM1 in inducing cell growth inhibition and apoptosis in prostate cancer cells. J Cell Biochem. 2011, 112 (1): 78-88. 10.1002\/jcb.22770.","journal-title":"J Cell Biochem"},{"issue":"5","key":"2126_CR34","doi-asserted-by":"publisher","first-page":"e5592","DOI":"10.1371\/journal.pone.0005592","volume":"4","author":"UG Bhat","year":"2009","unstructured":"Bhat UG, Halasi M, Gartel AL: Thiazole antibiotics target FoxM1 and induce apoptosis in human cancer cells. PLoS One. 2009, 4 (5): e5592-10.1371\/journal.pone.0005592.","journal-title":"PLoS One"},{"issue":"19","key":"2126_CR35","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.4161\/cc.10.19.17735","volume":"10","author":"B Pandit","year":"2011","unstructured":"Pandit B, Gartel AL: FoxM1 knockdown sensitizes human cancer cells to proteasome inhibitor-induced apoptosis but not to autophagy. Cell Cycle. 2011, 10 (19): 3269-3273. 10.4161\/cc.10.19.17735.","journal-title":"Cell Cycle"},{"issue":"1","key":"2126_CR36","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.canlet.2012.12.008","volume":"331","author":"K Qu","year":"2013","unstructured":"Qu K, Xu X, Liu C, Wu Q, Wei J, Meng F, Zhou L, Wang Z, Lei L, Liu P: Negative regulation of transcription factor FoxM1 by p53 enhances oxaliplatin-induced senescence in hepatocellular carcinoma. Cancer Lett. 2013, 331 (1): 105-114. 10.1016\/j.canlet.2012.12.008.","journal-title":"Cancer Lett"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1479-5876-11-265.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T19:13:01Z","timestamp":1630609981000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/1479-5876-11-265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,23]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2126"],"URL":"https:\/\/doi.org\/10.1186\/1479-5876-11-265","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,23]]},"assertion":[{"value":"28 June 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"265"}}